Cancer is not only one of the greatest medical challenges of our time…it’s also a large, lucrative, and dirty business.
In past articles, we’ve discussed the corruption of mainstream medicine, and the suppression of alternative cancer cures. When you follow the money, the motive is revealed: conventional cancer treatments rake in vast sums of money for all of the game’s players, which include oncologists, pharmaceutical companies, medical technology manufacturers, insurance companies, and even cancer research institutes.
And the racket is even more despicable than you may think. For example, even Breast Cancer Awareness Month is, in large part, a money-making scheme. It was initiated with support from the manufacturers of Tamoxifen (one of the leading chemo drugs) and General Electric, the manufacturers of mammogram devices.
The more “awareness” is raised around breast cancer, the more women pay for expensive mammograms (and thus the purchase of mammogram devices increases). Recent studies have found that an alarming number of benign tumors are misdiagnosed as malignant following mammograms, which in turn leads to greater usage of Tamoxifen and other chemo drugs.[1]
The point is that if effective cancer treatments are implemented on a widespread level, the profits of the cancer industry dry up.
Perhaps this is why the incidence of cancer continues to rise precipitously. Despite billions of taxpayers’ dollars being funneled into federal cancer research every year, we’re caught in a downward slide—in the beginning of the 20th century, 1 out of every 20 people got cancer within his or her lifetime; today, 1 out of every 3 people will be diagnosed with some form of cancer.
Antineoplastons: A Cure for Cancer Ignored For 45 Years?
By now, you’re probably aware that mainstream oncology’s stance on cancer treatment is pure propaganda. They maintain that diet and lifestyle modification play no role in the disease’s treatment, and claim that no treatment protocol besides surgery, chemo, and radiation have ever been proven to be effective. The mountain of research on turmeric, ginger, olive oil, and other anti-cancer functional foods clearly demonstrate that this simply isn’t the case.
Then, along comes the story of Dr. Stanislaw Burzynski and his incredible safe, alternative cancer cure.
Dr. Burzynski discovered yet another form of alternative cancer treatment over forty years ago. In the early 1970’s, he discovered that cancer patients lack certain peptides and amino acids. With this knowledge, he eventually developed a mixture of these compounds called antineoplastons, which he used to treat cancer at his private clinic.
Antineoplastons are a group of naturally-occurring peptides and amino acid derivatives which control tumor growth, and have been proven in clinical studies on a number of advanced cancer cases to be highly effective and non-toxic, relative to chemotherapy.
First identified by Dr. Stanislaw Burzynski in human blood in 1967, he observed “[T]here were significant differences in the peptide content in the serum of cancer patients as compared with the control group.”
Owing to the fact that similar peptide fractions are found in human urine and can be purified as a bulk source of antineoplastons, Dr. Burzynski began a research program “for the identification of antineoplastic peptides from urine” known as the Burzynski Research Institute (BRI), which was incorporated under the laws of the State of Delaware in 1984.
The discovery that urine contains therapeutic compounds is not novel. According to Dr. Burzynski:
“Medicinal use of urine and urine extracts has been known for centuries in ancient Egypt, Greece, Rome, India and North and Central America. In modern times, the first study of growth-inhibiting substances in urine was conducted in 1937. The research on urinary peptides has a long history and was initiated by a Polish researcher, S. Bondzynski, in 1897.”
GreenMedInfo.com has done an exhaustive index of the research on the topic as found on the National Library of Medicine, which can be found on its Antineoplastons research page. The information found there indicates the preventive and/or therapeutic value of antineoplaston therapy in up to 30 diseases.
The results have been remarkable. It turns out that antineoplastons target a wide array of cancer genes, effectively switching off the genes that promote cancer and switching on the genes that suppress it. In clinical trials, antineoplaston therapy cured 25% of adult patients with advanced cancer (vs. chemotherapy, which cured 9%), and 27.5% of children with advanced brain cancer (vs. chemotherapy, which cured only 0.9%).
Despite his success, Dr. Burzynski knew all along that offering alternative cancer treatments poses legal risks. To protect himself, he followed Texas state medical laws meticulously. He also patented his antineoplaston mixture, and set out to have the treatment approved by the FDA.
In a sane world, his work may have already revolutionized cancer treatment and saved the lives of millions of people by now. Instead, he has faced only brutal suppression, harassment, and legal backlash…and the siege continues even today.
Suppression at all costs
It is hard to fathom what Dr. Burzynski has been made to endure. His troubles began in 1977, when his requests for FDA review and approval were repeatedly denied. In 1984, he learned that the Texas Medical Board was trying to force his patients to file charges against him for fraudulent medical practice. None of them would comply, so the Board moved forward with filing their own groundless charges.
It took over a decade to bring Dr. Burzynski to trial, during which time it came to light that the FDA had been pressuring the Texas Medical Board all along. Over the course of another decade, Dr. Burzynski was taken to court three times, and every time was acquitted. No evidence could ever be produced suggesting that Dr. Burzynski broke any laws, or that his antineoplaston treatment was harmful, ineffective, or fraudulent in any way.
His patients never testified against him, and sixty of them even filed a petition requesting that the Board stop harassing their doctor.
In 1990, when Dr. Burzynski was still trying to stay out of court, he allied himself with Elan Pharmaceuticals, thinking that doing so would get the FDA and Texas Medical Board off his back. When Elan began to doubt whether they could hold the exclusive patent on the new treatment, though, they betrayed the doctor. They partnered with the National Cancer Institute instead of Dr. Burzynski, and designed a high-profile clinical study intended to invalidate the doctor’s work.
They selected only one of the antineoplaston ingredients (an unpatented one that they hoped to corner), which had already been proven ineffective on its own, and even sabotaged the study protocols by failing to administer the treatment to the majority of participants. Thus, when the results of the study were published, they cited antineoplaston therapy as a complete failure.
Shortly thereafter, the U.S. Department of Health and Human Services filed for patents on 11 of the antineoplaston ingredients for which Dr. Burzynski already held patents—and within ten years, the U.S. Patent Office approved all of them.
They’ve literally stolen his work right out from under him—and more changes are currently being brought against him, in order to ensure that he doesn’t have the time or freedom to fight back.
How you can help
The summary presented above is only the tip of the iceberg. For the full story, be sure to watch this incredible documentary about Dr. Burzynski’s work and tribulations:
You can also help protect him and the future of antineoplaston therapy by signing this petition. It’s up to us to fight against the unjust stranglehold on cancer treatment, and to fight for the rights of the brave and brilliant doctors who envision a world where cancer can cured safely and easily.
References
[1] http://healthimpactnews.com/2014/the-cancer-industry-is-too-prosperous-to-allow-a-cure/
[2] http://articles.mercola.com/sites/articles/archive/2011/06/11/burzynski-the-movie.aspx
